Abpro Holdings, Inc. (ABP)

NASDAQ: ABP · Real-Time Price · USD

0.2190

+0.0040 (1.86%)

Sep 8, 2025, 11:14 AM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Novel Antibodies	183.00K

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
United States	183.00K